BCRX
BioCryst Pharmaceuticals Inc
Price:  
4.41 
USD
Volume:  
2,557,481.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX Stock Forecast & Price Target

BCRX Stock Price Forecast

The average stock forecast for BioCryst Pharmaceuticals Inc (BCRX) in the next 12 months is 14.09 USD. This price target corresponds to an upside of 219.60%. The range of stock forecasts for BCRX is 6.06 - 31.50 USD. Based on the ratings of 18 analysts, the consensus recommendation for BCRX is BUY.
Target Low Average Median High
Price (USD) 6.06 14.09 11.22 31.50
Upside 37.41% 219.60% 154.42% 614.29%

Recommendation Trends

The latest consensus rating for BCRX is "BUY". This is the average recommendation of 18 analysts: 0 strong sell, 0 sell, 3 hold, 11 buy, 4 strong buy. In the previous period, 18 analysts also majorly recommmended "BUY" for BCRX.

BCRX Financial Stock Forecast

Revenue This Year
395.69M
19.39%
from 331.41M
Revenue Next Year
475.70M
20.22%
from 395.69M
EPS This Year
-0.62
-43.24%
from -1.10
EPS Next Year
-0.35
-44.01%
from -0.62